These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35793161)

  • 1. Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID.
    Boivineau G; Zallot C; Zerbib F; Plastaras L; Amiot A; Boivineau L; Koch S; Peyrin-Biroulet L; Vuitton L
    J Crohns Colitis; 2022 Dec; 16(12):1816-1824. PubMed ID: 35793161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-centre experience with anti-tumour necrosis factor treatment in budesonide-refractory microscopic colitis patients.
    Daferera N; Hjortswang H; Ignatova S; Münch A
    United European Gastroenterol J; 2019 Nov; 7(9):1234-1240. PubMed ID: 31700636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vedolizumab in Refractory Microscopic Colitis: An International Case Series.
    Rivière P; Münch A; Michetti P; Chande N; de Hertogh G; Schoeters P; Ferrante M; Vermeire S; Van Assche G
    J Crohns Colitis; 2019 Mar; 13(3):337-340. PubMed ID: 30329034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Non-Budesonide Therapies in Management of Microscopic Colitis: A Systematic Review and Meta-analysis.
    Rehde A; Hendel SK; Juhl CB; Gubatan J; Nielsen OH
    Drugs; 2023 Jul; 83(11):1027-1038. PubMed ID: 37358712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of biologic therapy in microscopic colitis: systematic review and meta-analysis.
    Taneja V; El-Dallal M; Anand RS; Haq Z; Mishkin B; Feuerstein JD
    Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1000-1006. PubMed ID: 36052677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulator therapy for microscopic colitis in a case series of 73 patients.
    Cotter TG; Kamboj AK; Hicks SB; Tremaine WJ; Loftus EV; Pardi DS
    Aliment Pharmacol Ther; 2017 Jul; 46(2):169-174. PubMed ID: 28488312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial.
    Münch A; Mihaly E; Nagy F; Madisch A; Kupčinskas J; Miehlke S; Bohr J; Bouma G; Guardiola J; Belloc B; Shi C; Aust D; Mohrbacher R; Greinwald R; Munck LK
    United European Gastroenterol J; 2021 Sep; 9(7):837-847. PubMed ID: 34414678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis.
    Münch A; Fernandez-Banares F; Munck LK
    Aliment Pharmacol Ther; 2013 Apr; 37(8):795-8. PubMed ID: 23432370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study.
    Hupé M; Rivière P; Nancey S; Roblin X; Altwegg R; Filippi J; Fumery M; Bouguen G; Peyrin-Biroulet L; Bourreille A; Caillo L; Simon M; Goutorbe F; Laharie D
    Aliment Pharmacol Ther; 2020 May; 51(9):852-860. PubMed ID: 32201971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study.
    Dhaliwal J; McKay HE; Deslandres C; Debruyn J; Wine E; Wu A; Huynh H; Carman N; Crowley E; Church PC; Walters TD; Ricciuto A; Griffiths AM;
    Aliment Pharmacol Ther; 2021 Jun; 53(12):1300-1308. PubMed ID: 33909911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Acid Sequestrant Therapy in Microscopic Colitis.
    Northcutt MJ; Gentile NM; Goldstein JL; Yen EF
    J Clin Gastroenterol; 2022 Feb; 56(2):161-165. PubMed ID: 33443968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study.
    Gentile NM; Abdalla AA; Khanna S; Smyrk TC; Tremaine WJ; Faubion WA; Kammer PP; Sandborn WJ; Loftus EV; Pardi DS
    Am J Gastroenterol; 2013 Feb; 108(2):256-9. PubMed ID: 23295275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group.
    Fernández-Bañares F; Casanova MJ; Arguedas Y; Beltrán B; Busquets D; Fernández JM; Fernández-Salazar L; García-Planella E; Guagnozzi D; Lucendo AJ; Manceñido N; Marín-Jiménez I; Montoro M; Piqueras M; Robles V; Ruiz-Cerulla A; Gisbert JP;
    Aliment Pharmacol Ther; 2016 Feb; 43(3):400-26. PubMed ID: 26597122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with long-term clinical outcome in microscopic colitis.
    Miyatani Y; Komaki Y; Komaki F; Micic D; Keyashian K; Sakuraba A
    Ann Med; 2024 Dec; 56(1):2365989. PubMed ID: 38900021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials.
    Chande N; MacDonald JK; McDonald JW
    Am J Gastroenterol; 2009 Jan; 104(1):235-41; quiz 234, 242. PubMed ID: 19098875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for treating lymphocytic colitis.
    Chande N; Al Yatama N; Bhanji T; Nguyen TM; McDonald JW; MacDonald JK
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006096. PubMed ID: 28702956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).
    Sassaki LY; Magro DO; Saad-Hossne R; Baima JP; Flores C; Correia LM; Celani LMS; De Abreu Ferrari ML; Zacharias P; Feitosa MR; Dos Santos CHM; De Freitas Lins Neto MA; Quaresma AB; De Lima Junior SF; De Vasconcelos GBS; Cassol OS; Dos Santos Pinto A; Kurachi G; Goncalves Filho FA; Gasparini RG; Furlan TK; Catapani WR; Coy CSR; De Souza Menegassi V; Colombo MM; Fróes RSB; Teixeira FV; Moraes AC; Santana GO; Parente JML; Vilela EG; Queiroz NSF; Kotze PG;
    BMC Gastroenterol; 2022 May; 22(1):268. PubMed ID: 35644668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term follow-up of inflammatory bowel disease patients receiving anti-tumor necrosis factor-alpha therapy].
    Bacsur P; Skribanek S; Milassin Á; Farkas K; Bor R; Fábián A; Rutka M; Bálint A; Szántó KJ; Tóth T; Nagy F; Szepes Z; Boda K; Molnár T
    Orv Hetil; 2020 Nov; 161(47):1989-1994. PubMed ID: 33226355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of budesonide in the treatment of microscopic colitis.
    Tangri V; Chande N
    Saudi J Gastroenterol; 2010; 16(3):236-8. PubMed ID: 20616427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis.
    Tome J; Tariq R; Hassett LC; Khanna S; Pardi DS
    Inflamm Bowel Dis; 2024 Jul; 30(7):1178-1188. PubMed ID: 37589651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.